Cargando…
Higher Plasma APOC-III Was Associated with a Slower Reduction of β-Amyloid Levels in Cerebrospinal Fluid Among Older Individuals Without Dementia
PURPOSE: Although emerging evidence has suggested that apolipoprotein C-III (APOC-III) is involved in the pathogenesis of Alzheimer’s disease (AD), the association of APOC-III with longitudinal changes in cerebrospinal fluid (CSF) AD pathologies (β-amyloid (Aβ42) and tau proteins) is not clear. In t...
Autor principal: | Zhang, Xiaoyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213010/ https://www.ncbi.nlm.nih.gov/pubmed/32440128 http://dx.doi.org/10.2147/NDT.S238985 |
Ejemplares similares
-
Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
por: van Steenoven, Inger, et al.
Publicado: (2019) -
Cerebrospinal fluid analysis in individuals with diabetes-related dementia
por: Kanetaka, Hidekazu, et al.
Publicado: (2017) -
Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia
por: Bibl, Mirko, et al.
Publicado: (2012) -
APOC-III: a Gatekeeper in Controlling Triglyceride Metabolism
por: Giammanco, Antonina, et al.
Publicado: (2023) -
Higher CSF sTREM2 and microglia activation are associated with slower rates of beta‐amyloid accumulation
por: Ewers, Michael, et al.
Publicado: (2020)